LONDON STOCK EXCHANGE · AZN

-0.12% · -$0.2000 · Vol 2.4M

Market closed · last close 4:00 PM ET · price as of 19:21:04 ET

AstraZeneca PLC

Pharmaceuticals

$161.30

Card

Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factors

Thu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET · AZN

Methodology

AZN

AstraZeneca PLC

Thu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET

54/100

NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

54/ 100

Veridion Score

NEUTRAL · HIGH confidence

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6/6 factors with data · Thu Aug 6 · market closed · Markets closed · resumes Fri 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is AZN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move AZN next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Aug 6
Score
Score moved +8
46/NEUTRAL -> 54/NEUTRAL
Veridion score historySource
Mar 31
CongressChecking access
Alan Armstrong purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Mar 30
CongressChecking access
Alan Armstrong purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Mar 13
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Feb 13
CongressChecking access
Ro Khanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Dec 18
CongressChecking access
Gilbert Ray Cisneros, Jr. purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Dec 8
CongressChecking access
Julia Letlow purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Nov 19
CongressChecking access
Gilbert Ray Cisneros, Jr. purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Oct 31
CongressChecking access
Lisa C. McClain sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About AstraZeneca PLC

Pharmaceuticals

Listed since

2009

Employees

96K

Country

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$162.62

Day high

$162.93

Day low

$159.75

Previous close

$161.50

52W high

$209.48

-23.00% from high

52W low

$147.06

23% of range

Market cap

$250.5B

P/E

24.05×

EPS

$6.69

Beta

-0.05

Shares out

1.6B

Volume

2.4M

0.67× rel vol

Avg volume

3.5M

VWAP

$160.87

Price history computed in-house

-4.92%

-14.78%

-11.79%

+8.15%

YTD

-12.27%

SMA 50 $176.85 · below

SMA 200 $184.59 · below

52W position 23%

AZN overview

Veridion Score

6 of 6 factors measured

Congress receipts

Alan Armstrong · Purchase

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around AZN.Congress disclosuresOpen receipt and filing context for AZN.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

AZN insider activity

AstraZeneca PLC

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not evaluated: the SEC filing index could not be read

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

No value-bearing Form 4 rows

The current Form 4 feed did not return value-bearing open-market rows for AZN.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in AZN

Congress tracker Open ticker disclosure ledger →

Alan ArmstrongBuyself

AstraZeneca PLC Ordinary Shares · Transaction Mar 31, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000

Official filing ↗

Alan ArmstrongBuyself

AstraZeneca PLC Ordinary Shares · Transaction Mar 30, 2026 · Filed Jul 21, 2026 · $15,001 to $50,000

Official filing ↗

Ro KhannaBuy

AZN Common Stock · Transaction Mar 13, 2026 · Filed Apr 7, 2026 · Amount pending receipt enrichment

Official filing ↗

Ro KhannaSell

AZN Common Stock · Transaction Feb 13, 2026 · Filed Mar 9, 2026 · Amount pending receipt enrichment

Official filing ↗

Hon. Gilbert CisnerosSell

Bank of America AstraZeneca PLC - American Depositary Shares · Transaction Dec 19, 2025 · Filed Date unavailable · $1,001 to $15,000

Official filing ↗

Federal contracts

AZN contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for AZN in this window.

Lobbying spend

AZN lobbying filings, year to date.

Registered lobbying filings matched to AstraZeneca PLC.

$4.8M

Refresh interval: 12hSource: LDA disclosure filings

Health Issues Medicare/MedicaidHealth Issues Medicare/Medicaid Pharmacy Copyright/Patent/Trademark Tariff (miscellaneous tariff bills) Trade (domestic/foreign) Labor Issues/Antitrust/Workplace Taxation/Internal Revenue CodeHealth Issues Medicare/Medicaid Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills) Trade (domestic/foreign)

Filing

$2.3M

ASTRAZENECA PHARMACEUTICALS LP

Apr 20, 2026

Filing

$1.7M

ASTRAZENECA PHARMACEUTICALS LP

Jul 20, 2026

Filing

$670.0K

ASTRAZENECA PHARMACEUTICALS LP

Jan 20, 2026